-
December 17, 2018
Precision Medicine Group Acquires Stern Investor Relations, Inc.
Read more... -
December 3, 2018
Clinical Omics - Unlocking the Value of Complex Biomarker Data
Discover more... -
October 16, 2018
Precision for Medicine Acquires Liquid Biopsy and Tissue Profiling Pioneer ApoCell
Get the story...
Precision for Medicine can help you find and extract the long-term value of innovative drugs
We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. And we’re constantly adding services and expertise under that roof to support medical innovators — like our recent acquisition of ETHOS Health Communications, specializing in the interpretation and communication of medical science. In short: Precision dramatically accelerates your pathway from proof of concept to drug approval.

